Hyaluronidases were initially classified in 1971 by a German biochemist named Karl Meyer. He grouped them into three distinct classifications that include a prokaryotic lyase-type of glycosidase and two classes of eukaryotic endoglycosidase hydrolases.
Get a Fast and Easy
API Quote.
Special Active Pharmaceutical ingredients (GMP)
Full GMP API Product List
DownloadInsights and news worth sharing.
GS-441524: A Strategic Antiviral Opportunity for Greece’s Expanding Veterinary Market
GS-441524: Elevate Precision Antiviral Compounding in Italy’s Veterinary Market
GS-441524: Advancing Feline Antiviral Solutions in Luxembourg’s Innovative Veterinary Market
GS-441524: Precision Antiviral Solutions for Germany’s Evolving Feline Care Market
GS-441524: Meeting the Needs of Spain’s Expanding Feline Population
Lead the Way in Cyprus: Unlock the Potential of Advanced Feline Antivirals with GS-441524
GS-441524: Capture First-Mover Advantage in Romania’s Emerging Antiviral Market
GS-441524: Unlock Premium Margins for Ireland’s Compounding Pharmacists